Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
Stocks · News reference
RBC has increased its price target for Bausch Health Companies Inc. to $10 from $9 while maintaining a Sector Perform rating.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
Bausch Health reported strong third-quarter 2026 financial results, including a 10% increase in consolidated revenues and an increase in adjusted earnings per share, leading the company to raise its financial guidance.
Bausch Health plans to redeem approximately $643 million of its outstanding 8.500% senior notes due in 2027 using cash on hand.